FDA approvals

Orca

Pharma

Orca Bio takes commercial leap with FDA approval for Tregzi

Orca Bio is charging the WAC of $428,000 for Tregzi, a novel regulatory T cell-based therapy for blood cancer patients requiring transplants.

Angus Liu Jul 1, 2026 12:14am

race car photo finish speed fast

AZ, Daiichi's Datroway approved in first-line TNBC

May 22, 2026 11:32am

Enhertu

Enhertu secures dual FDA approvals in early breast cancer

May 18, 2026 10:52am

A photo finish at a horse race with both horses crossing the finish line

Pfizer, Arvinas' breast cancer med wins FDA approval

May 1, 2026 3:50pm

Human kidney anatomy

In another win for rare disease, Travere nabs FDA’s first FSGS nod

Apr 13, 2026 6:25pm

FDA approved stamp regulations yes go

AZ nabs Calquence fixed-duration nod to counter BeOne’s CLL push

Feb 20, 2026 11:05am